Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Patient Risk Stratification Market Be Worth By 2029?

The market size for patient risk stratification has seen an exceptional rise in recent times. The growth is projected to move from $2.15 billion in 2024 to $2.81 billion in 2025, marking a compound annual growth rate (CAGR) of 30.9%. The notable growth during the historic phase can be ascribed to a heightened adoption of digitization, escalated risk levels, an increasing older population, a higher rate of medical errors, and the growing embrace of electronic health records (EHR).

The market size for patient risk stratification is projected to experience a substantial increase in the forthcoming years, potentially reaching a value of $8.2 billion by 2029, with a compound annual growth rate (CAGR) of 30.7%. This projected increase during the forecast period is likely due to a combination of factors such as the upsurge of middle-class populations and health insurance, increased cases of chronic diseases, accelerated adoption of predictive analytics, a growing focus on social determinants of health (SDOH), and the widespread utilization of technology. The forecast period is set to be characterized by significant trends such as the progress in analytics, artificial intelligence (AI), machine learning, technological advancements specific to healthcare, the introduction of innovative tools, the enhancement of wearable technology, and the expansion of remote monitoring.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20917&type=smp

What External And Internal Drivers Are Influencing The Patient Risk Stratification Market?

The escalating prevalence of chronic diseases is anticipated to fuel the expansion of the patient risk stratification market in the future. Chronic illnesses present persistent health situations that generally last for three months or more. The increasing prevalence of such diseases can be linked to factors like an aging demographic, poor lifestyles, urban growth, ecological factors, inadequate healthcare services, economic inequality, and heightened stress. Patient risk stratification plays a crucial role in distinguishing individuals at varying risk degrees for chronic illnesses, offering customized care and early intervention, promoting efficient resource distribution, and enhancing healthcare results. For example, stats from the National Center for Biotechnology Information (NCBI), an American National Library of Medicine, predicted in January 2023 that there would be an estimated surge of 99.5% of individuals aged 50 and above suffering at least one chronic disease, from 71.522 million in 2020 to 142.66 million by 2050. Additionally, a report from the World Health Organization (WHO) 2022 Highlights, a Swiss-based intergovernmental health body, disclosed that chronic illnesses constituted 74% of the entire global death toll, amounting to 41 million deaths every year, in September 2022. Cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes caused 17.9 million, 9.3 million, 4.1 million, and 2.0 million deaths respectively. Consequently, the escalating prevalence of chronic diseases catapults the demand in the patient risk stratification market.

What Segmentation Insights Are Provided In The Patient Risk Stratification Market Research?

The patient risk stratificationmarket covered in this report is segmented –

1) By Type: Predictive Risk Stratification Model; Retrospective Risk Stratification Model; Prospective Risk Stratification Model; Concurrent Risk Stratification Model

2) By Component: Software; Services

3) By Delivery Model: On-Premise; Cloud-Based

4) By Application: Risk Adjustment; Clinical Workflow; Revenue Cycle Management; Other Applications

5) By End User: Healthcare Providers; Healthcare Payers; Other End Users

Subsegments:

1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models; Statistical Predictive Models; AI-Powered Predictive Models

2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models; Data Mining Retrospective Models

3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models; Real-Time Risk Assessment Models

4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models; Real-Time Clinical Decision Support Models

Which Trends Are Likely To Redefine Growth Paths In The Patient Risk Stratification Market?

Leading businesses in the patient risk stratification market are homing in on advanced healthcare technologies, including artificial intelligence (AI) in disease detection, as a way to enhance early diagnosis, optimize patient results, and decrease healthcare expenses by ensuring precise risk evaluations and tailor-made treatment strategies. The use of AI in disease detection deploys intricate algorithms and machine learning to scrutinize medical records, facilitating swift detection of diseases and improvement of diagnostic precision through rapid analysis of vast data volumes. For example, WELL Health Technologies Corporation, a Canadian healthcare firm, and its subsidiary HEALWELL AI, which is also a Canada-based healthcare company concentrating on AI and data science for preventive healthcare, unveiled WELL AI Decision Support (WAIDS) in May 2024. It focuses on rare diseases but now extends to screen chronic ailments such as kidney disease, hypertension, and diabetes. It has the capacity to diagnose over 100 diseases and deliver risk stratification, assisting medical professionals in identifying care deficits and obtaining actionable data at the point of care.

Who Are The Leading Companies Driving The Patient Risk Stratification Market?

Major companies operating in the patient risk stratification market are Bristol-Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Sales Force Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Adobe Inc., Persistent Systems, NextGen Healthcare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., American Academy of Family Physicians, Lightbeam Health Solutions, Graphnet Health Ltd., Innova Medical Group Inc., Equipo Health Inc., Epic Systems Corporation

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/patient-risk-stratification-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Patient Risk Stratification Market?

North America was the largest region in the patient risk stratification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient risk stratification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=20917&type=smp

Browse Through More Reports Similar to the Global Patient Risk Stratification Market 2025, By The Business Research Company

Patient Portal Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-portal-global-market-report

Patient Safety And Risk Management Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-safety-and-risk-management-software-global-market-report

Patient Registry Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-registry-software-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model